Improved performance of first-trimester combined screening for trisomy 21 with the double test taken before a gestational age of 10 weeks

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Improved performance of first-trimester combined screening for trisomy 21 with the double test taken before a gestational age of 10 weeks. / Kirkegaard, Ida; Petersen, Olav Bjørn; Uldbjerg, Niels; Tørring, Niels.

In: Prenatal Diagnosis, Vol. 28, No. 9, 2008, p. 839-844.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Kirkegaard, I, Petersen, OB, Uldbjerg, N & Tørring, N 2008, 'Improved performance of first-trimester combined screening for trisomy 21 with the double test taken before a gestational age of 10 weeks', Prenatal Diagnosis, vol. 28, no. 9, pp. 839-844. https://doi.org/10.1002/pd.2057

APA

Kirkegaard, I., Petersen, O. B., Uldbjerg, N., & Tørring, N. (2008). Improved performance of first-trimester combined screening for trisomy 21 with the double test taken before a gestational age of 10 weeks. Prenatal Diagnosis, 28(9), 839-844. https://doi.org/10.1002/pd.2057

Vancouver

Kirkegaard I, Petersen OB, Uldbjerg N, Tørring N. Improved performance of first-trimester combined screening for trisomy 21 with the double test taken before a gestational age of 10 weeks. Prenatal Diagnosis. 2008;28(9):839-844. https://doi.org/10.1002/pd.2057

Author

Kirkegaard, Ida ; Petersen, Olav Bjørn ; Uldbjerg, Niels ; Tørring, Niels. / Improved performance of first-trimester combined screening for trisomy 21 with the double test taken before a gestational age of 10 weeks. In: Prenatal Diagnosis. 2008 ; Vol. 28, No. 9. pp. 839-844.

Bibtex

@article{cca9c7553efb45198629baa88548fc5c,
title = "Improved performance of first-trimester combined screening for trisomy 21 with the double test taken before a gestational age of 10 weeks",
abstract = "OBJECTIVE: To evaluate if there is a performance difference in the combined screening for trisomy 21 between the double tests performed before and after 10 + 0 weeks of gestation.METHODS: The study included all 97 trisomy 21 cases from January 2004 to December 2007, in a screening program where the double test was measured in week 8 + 0 to 13 + 6 and the nuchal translucency in week 11 + 3 to 13 + 6.RESULTS: As many as 87 of the 97 cases were diagnosed in the screening program (detection rate = 90%). Among the 53 cases having the double test taken before 10 + 0 weeks, no cases were missed [detection rate (DR) = 100%, CI = 0.94-1.00] and among the 44 having the double test taken after 10 + 0 weeks, 10 cases were missed (DR = 77%, CI = 0.65-0.90). This difference in DR was highly significant (P = 0.0009). No difference was observed between false positive rates or median maternal age of the two groups.CONCLUSION: A significantly higher DR was obtained when the double test was taken early in pregnancy (<10 + 0 weeks), than when it was taken later (>or=10 + 0 weeks). The results could not be explained by a difference in either the false positive rate or the maternal age between the two groups.",
keywords = "Adult, Chorionic Gonadotropin, beta Subunit, Human/blood, Down Syndrome/diagnosis, False Negative Reactions, False Positive Reactions, Female, Gestational Age, Humans, Middle Aged, Pregnancy, Pregnancy Trimester, First, Pregnancy-Associated Plasma Protein-A/analysis, Ultrasonography, Prenatal, Young Adult",
author = "Ida Kirkegaard and Petersen, {Olav Bj{\o}rn} and Niels Uldbjerg and Niels T{\o}rring",
note = "Copyright (c) 2008 John Wiley & Sons, Ltd.",
year = "2008",
doi = "10.1002/pd.2057",
language = "English",
volume = "28",
pages = "839--844",
journal = "Prenatal Diagnosis",
issn = "0197-3851",
publisher = "JohnWiley & Sons Ltd",
number = "9",

}

RIS

TY - JOUR

T1 - Improved performance of first-trimester combined screening for trisomy 21 with the double test taken before a gestational age of 10 weeks

AU - Kirkegaard, Ida

AU - Petersen, Olav Bjørn

AU - Uldbjerg, Niels

AU - Tørring, Niels

N1 - Copyright (c) 2008 John Wiley & Sons, Ltd.

PY - 2008

Y1 - 2008

N2 - OBJECTIVE: To evaluate if there is a performance difference in the combined screening for trisomy 21 between the double tests performed before and after 10 + 0 weeks of gestation.METHODS: The study included all 97 trisomy 21 cases from January 2004 to December 2007, in a screening program where the double test was measured in week 8 + 0 to 13 + 6 and the nuchal translucency in week 11 + 3 to 13 + 6.RESULTS: As many as 87 of the 97 cases were diagnosed in the screening program (detection rate = 90%). Among the 53 cases having the double test taken before 10 + 0 weeks, no cases were missed [detection rate (DR) = 100%, CI = 0.94-1.00] and among the 44 having the double test taken after 10 + 0 weeks, 10 cases were missed (DR = 77%, CI = 0.65-0.90). This difference in DR was highly significant (P = 0.0009). No difference was observed between false positive rates or median maternal age of the two groups.CONCLUSION: A significantly higher DR was obtained when the double test was taken early in pregnancy (<10 + 0 weeks), than when it was taken later (>or=10 + 0 weeks). The results could not be explained by a difference in either the false positive rate or the maternal age between the two groups.

AB - OBJECTIVE: To evaluate if there is a performance difference in the combined screening for trisomy 21 between the double tests performed before and after 10 + 0 weeks of gestation.METHODS: The study included all 97 trisomy 21 cases from January 2004 to December 2007, in a screening program where the double test was measured in week 8 + 0 to 13 + 6 and the nuchal translucency in week 11 + 3 to 13 + 6.RESULTS: As many as 87 of the 97 cases were diagnosed in the screening program (detection rate = 90%). Among the 53 cases having the double test taken before 10 + 0 weeks, no cases were missed [detection rate (DR) = 100%, CI = 0.94-1.00] and among the 44 having the double test taken after 10 + 0 weeks, 10 cases were missed (DR = 77%, CI = 0.65-0.90). This difference in DR was highly significant (P = 0.0009). No difference was observed between false positive rates or median maternal age of the two groups.CONCLUSION: A significantly higher DR was obtained when the double test was taken early in pregnancy (<10 + 0 weeks), than when it was taken later (>or=10 + 0 weeks). The results could not be explained by a difference in either the false positive rate or the maternal age between the two groups.

KW - Adult

KW - Chorionic Gonadotropin, beta Subunit, Human/blood

KW - Down Syndrome/diagnosis

KW - False Negative Reactions

KW - False Positive Reactions

KW - Female

KW - Gestational Age

KW - Humans

KW - Middle Aged

KW - Pregnancy

KW - Pregnancy Trimester, First

KW - Pregnancy-Associated Plasma Protein-A/analysis

KW - Ultrasonography, Prenatal

KW - Young Adult

U2 - 10.1002/pd.2057

DO - 10.1002/pd.2057

M3 - Journal article

C2 - 18677711

VL - 28

SP - 839

EP - 844

JO - Prenatal Diagnosis

JF - Prenatal Diagnosis

SN - 0197-3851

IS - 9

ER -

ID: 227523583